Senior insider sale
Chief Business Officer at OVID THERAPEUTICS INC. — senior position signals high conviction
$420.0K
150K shares
What this filing means
RONA JEFFREY A plans to sell 150K shares of OVID THERAPEUTICS INC. valued at approximately $420.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2026ACC: 0001311404-26-000005
Officer· Chief Business Officer
Since Sep 2020
150K
Shares to sell
$420.0K
Approx. market value
150K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months11
Stock Option Exercise
Cash
8/14/2026
85.03KESPP Purchase
Cash
3/20/2026
2.50KESPP Purchase
Cash
9/19/2025
5KESPP Purchase
Cash
3/20/2025
5KRestricted Stock Units
Compensation
2/20/2025
14.88KESPP Purchase
Cash
9/20/2024
5KESPP Purchase
Cash
3/20/2024
3.12KRestricted Stock Units
Compensation
2/22/2024
18.84KESPP Purchase
Cash
9/20/2023
3.67KESPP Purchase
Cash
3/20/2023
4.43KESPP Purchase
Cash
3/20/2022
2.54KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/14/2026 | Stock Option Exercise Cash | 85.03K | — |
3/20/2026 | ESPP Purchase Cash | 2.50K | — |
9/19/2025 | ESPP Purchase Cash | 5K | — |
3/20/2025 | ESPP Purchase Cash | 5K | — |
2/20/2025 | Restricted Stock Units Compensation | 14.88K | — |
9/20/2024 | ESPP Purchase Cash | 5K | — |
3/20/2024 | ESPP Purchase Cash | 3.12K | — |
2/22/2024 | Restricted Stock Units Compensation | 18.84K | — |
9/20/2023 | ESPP Purchase Cash | 3.67K | — |
3/20/2023 | ESPP Purchase Cash | 4.43K | — |
3/20/2022 | ESPP Purchase Cash | 2.54K | — |
| Total | 150K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
150K
Market value
$420.0K
8/14/2026
Total
Units
150K
Value
$420.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2026 | 150K | $420.0K | Nasdaq | Planned |
| Total | 150K | $420.0K | ||